Interested in speaking? Apply Here!

Agenda

MAIN CONFERENCE DAY ONE | Tuesday, April 30, 2019
7:45AM
Registration and Morning Coffee
8:30AM
CO-CHAIRS' OPENING KEYNOTE
Strategic Vision: A Global Strategic Vision for Digital Health in Pharma
  • Digital health has been a massive movement throughout all corners of the global healthcare ecosystem, yet life science organizations are just now getting serious about the opportunities
  • This conference offers the first-ever focused opportunity for life science leaders to convene and discuss these possibilities across the value chain and their organizations, and hopefully drive our industry forward
  • An overview of the value models for digital health in the life sciences, and how life science organizations can think about how to (eventually) drive commercial value from digital health initiatives
    • "Invest"
    • "Incubate/Accelerate"
    • "Commercialize"
    • "Collaborate"
    • "Co-Develop"
Larry Brooks, Principal, Digital Health Practice Leader, EVOLUTION ROAD
Paul Ivans, Founder and CEO, EVOLUTION ROAD
9:00AM
PHARMA KEYNOTE
Pharma's Path to Digital Health Disruption: Driving Organizational Change to Succeed in a Constantly Connected World

Pharma certainly hasn’t developed a reputation as the industry driving innovation and excellence in customer experience. But in today’s world, where patients are smarter and more in control of their health than ever before, the necessity for excellence across modern engagement and digital health techniques has never been more important. So how do we shift historically traditional organizations to not just show up — but to break through — in digital health and social media? Hear how GSK is fostering in a new era of patient engagement — bringing the organization on a journey toward digital disruption by putting patients at the center and designing integrated online experiences that are primed for discovery, engagement, and outcomes.

Angela Horstmann, Head of Consumer Digital Experience and Innovation, U.S. PharmaCustomer Capabilities and Operations, GLAXOSMITHKLINE
Andy Kennemer, Vice President, Digital Customer Experience and Innovation, GLAXOSMITHKLINE
9:00AM
PHARMA KEYNOTE
Strategic Vision for Digital Health in Pharma - The Global/U.S. Perspective
Shwen Gwee, General Manager, Digital Accelerator, Global Drug Development, NOVARTIS
10:00AM
REGULATORY CASE STUDY
Integrating Patient Feedback Into the Drug and Digital Therapeutics Development Process

Profiling the work of the NIH with the FDA and Patient Advocacy Groups to identify additional clinical endpoints for SaMD approval process

Victor Prikhodko, Business Advisor and Scientific Program Manager [C], NIDA, OD, OTIPI
10:30AM
Morning Networking Break
11:00AM
Panel Discussion

Digital Therapeutics: Understanding this growing area within digital health, and learning how life science organizations can effectively collaborate and partner to help solve unmet customer needs?

Learn about the rapidly evolving and growing area of digital therapeutics and how these “hot companies” are viewing the life science industry, and how they are partnering with your peers and competitors today.

Moderator:

Megan Coder, Executive Director, DIGITAL THERAPEUTICS ALLIANCE

Panelists:

Joel Sangerman, Chief Commercial Officer, CLICK THERAPEUTICS, INC.

11:30AM
Panel Discussion "INVEST"
Digital Health Investor Panel - A View From the Other Side - Pharma Investors, Private Equity/Venture Capital
Panelists:

Gary Kurtzman, Managing Diector, Healthcare, SAFEGUARD SCIENTIFICS
Sasha Said, Vice President, Digital Health investor, LEERINK TRANSFORMATION PARTNERS

12:00PM
PHARMA KEYNOTE
Session Title to Be Determined
Thomas McCourt, Chief Commercial Officer and Senior Vice President, Marketing and Sales, IRONWOOD PHARMACEUTICALS
12:30PM
PHARMA KEYNOTE
The Hammer of Disruption: Surviving, Thriving, and Staying Alive in a Mid-Disruption Ecosystem

It's not (just) the tech: why partnering and business models enable the future of patient care

  • Identifying new products and services relevant to neurology patients
  • Cultivating partnerships and pursuing strategic opportunities with mission-driven companies
  • Designing new business models orientated toweard increased value delivery to health systems, improved patient experience and outcomes
James Musick, Vice President, Head of Neurology Patient Technology U.S., UCB PHARMACEUTICALS
1:00PM
Networking Luncheon
2:00PM
PHARMA KEYNOTE
Thinking Differently to Take Advantage of Digital Health Innovation Techniques In-House and Agility Measures
Nicole Mowad-Nassar, Vice President, Commercial Analytics and Innovation, ABBVIE
2:30PM
PHARMA KEYNOTE
Session Title to Be Determined
Rachel Sha, Vice President, Digital Business Development, SANOFI
3:00PM
PHARMA KEYNOTE "CO-DEVELOP"
A View of Digital Health From the Clinical Side of Pharma

Analyzing the Importance of Incorporating Data Driven Decision Making in Company Culture and Enabling This Through Data and Technology

Miruna Sasu, Head of Innovation and Digital Health, BRISTOL-MYERS SQUIBB
3:30PM
Panel Discussion PHARMA DIGITAL HEALTH THOUGHT LEADERS KEYNOTE: Pulling Perspectives Together
  1. Invest
  2. Incubate/Accelerate
  3. Commercialize
  4. Collaborate
  5. Co-Develop
Moderator:

Paul Ivans, Founder and CEO, EVOLUTION ROAD

Panelists:

Shwen Gwee, General Manager, Digital Accelerator, Global Drug Development, NOVARTIS
James Musick, Vice President, Head of Neurology Patient Technology U.S., UCB PHARMACEUTICALS
Amy West, Senior Director, Patient Marketing and Digital Health Innovation, NOVO NORDISK

4:00PM
Afternoon Networking and Refreshment Break
MAIN CONFERENCE DAY ONE TRACKED SESSIONS | Tuesday, April 30, 2019
TRACK A
Digital Health + Patient Engagement Intersect

TRACK B
Digital Health Case Studies in the Real World

4:40PM
Track Chair's Opening Remarks
Track Chair's Opening Remarks
4:45PM
CASE STUDY
Digital Connectivity and Its Role in Disease Management and Patient Engagement
  • Examining the role digital connectivity has in patient disease management and support beyond adherence
  • Understanding and balance technical complexity and simplicity to create a unique and positive user experience
  • Polymedicine challenges and consideration — short-term approach and long-term considerations
  • Exploring opportunities for pharma, patient and HCP engagement through digital support ecosystem
Michael C. Song, Ph.D., Senior Manager R&D, Device Functionality, Safety, and Digital Connectivity, Drug Delivery and Device Development, BioPharmaceutical Development, MEDIMMUNE
CASE STUDY
Session Title to Be Determined
5:15PM
Panel Discussion Patient Influencers Weigh In on Digital Health Adoption

Abstract:

For all its promise, consumer digital health adoption remains a daunting challenge for most pharma companies. There are few if any magic bullets, but plenty of lessons to be learned from patient influencers who understand the adoption challenge as well as anyone. In fact, trusted patient thought leaders are one of the most overlooked allies pharma companies have when it comes to building and marketing new solutions to the broader patient community. Hear from patients with hands-on experience in digital health – what works, what doesn’t and how to innovate with patients, not just for them.

Moderator:

Jack Barrette, CEO, WEGO HEALTH

Panelists:

Kristen Winters, Integrated Multichannel Marketing and Sales Lead, US Market, Process and Platforms, BAYER

CASE STUDY
Digital Biomarkers in Clinical Trials - Learnings and Prospects

Digital devices such as activity monitors enable the collection of continuous real-world data that provide valuable new insights into the impact of diseases and treatments on patients’ everyday lives. As the implementation of such devices in clinical trials increases, reflecting on case studies and the lessons learned will allow us to overcome the challenges and embrace the opportunities.

Jonas Dorn, Digital Solutions Director, NOVARTIS
5:45PM
CASE STUDY
The Who, What, When, Where and How of Digital Health
To many Pharma companies, Digital Health brings to mind initiatives focusing on what innovations we can deliver and how they can benefit our patients. However, who these patients are and when they are interacting with Pharma brands can sometimes receive less attention. Nevertheless, these considerations are vitally important to creating solutions that provide lasting value. In this session, we’ll explore ways to develop digital health initiatives that fully integrate all customers’ needs
Fred Bennett, Head, Patient Strategy and Engagement, INTERCEPT PHARMACEUTICALS
CASE STUDY
Digitally Detecting Developing Diseases – Computational Intelligence Synergistically Applied to Medical Data and LIFEdata
  • Hear how BioTrillion is developing a health technology platform called BioEngine4D, by applying machine learning and AI to aggregated Medical data and unique LIFEdata — now generatable via the ubiquity of multi-modality sensors existing within key Consumer smart devices
  • Learn how novel digital biomarkers can be developed by computationally training and statistically mapping key diseases, via pathophysiologic-known pathways, to digitally measurable expressions
  • Explore how BioEngine4D can yield entirely new opportunities — to augment existing molecular biomarkers, early detect, and develop novel therapeutics — for a broad array of diseases, such as Alzheimer’s, Parkinson’s, Lung Cancer, and Melanoma
  • Consider how novel uses of multimodal sensors within common smartphones and smartwatches can effectively:
    • Place “a digital doctor” in your Life setting to continuously check for key disease indicators and catalyze earlier clinical diagnoses and timelier intervention
    • Place “clinical trials in a pocket” and disrupt the slow and costly pharma drug development paradigm
Savan Devani, Founder and CEO, BIOTRILLION
6:15PM
Conclusion of Day One and Networking Cocktail Reception
MAIN CONFERENCE DAY TWO | Wednesday, May 1, 2019
8:15AM
Registration Opens and Morning Coffee
8:40AM
Co-Chairs' Opening Remarks for Day Two
Larry Brooks, Principal, Digital Health Practice Leader, EVOLUTION ROAD
Paul Ivans, Founder and CEO, EVOLUTION ROAD
9:00AM
PHARMA KEYNOTE
Incorporating Behavioral Science in Your Next Digital Innovation
Daniel Seewald, Worldwide Head of Innovation, PFIZER, INC.
9:30AM
PHARMA KEYNOTE
Digital Health As a Solution, Not Just "Digital": How to Bring the Conversation to Life for Digital Health and Elevate the Conversation to a Level CEOs Care About
Pete Dannenfelser, Associate Vice President Communications and Digital Innovation, FERRING PHARMACEUTICALS
10:00AM
FIRESIDE CHAT 'CO-DEVELOP'
Faster, Smarter, Bigger: Better Together
  • Digital trens from Google's persepctive
  • The power of partnerships: The "Why", "What", and "How" answered
Stefani Klaskow, Head of Industry, Healthcare, GOOGLE
Melissa Saw, Global Head, Digital Partnerships, BAYER
10:30AM
Panel Discussion "INCUBATE" Accelerators, Incubators, Innovators, Oh My!
Panelists:

Melissa Saw, Global Head, Digital Partnerships, BAYER
Unity Stoakes, Co-Founder, STARTUP HEALTH

11:00AM
Morning Networking Break
11:30AM
PHARMA KEYNOTE
Session Title to Be Determined
Aman Bhatti, Global CHC Medical Head, Digital Health and Medicines, SANOFI
12:00PM
Panel Discussion Payer Perspectives on Digital Health: How Payers View Digital Health and Pharma's Role in Digital Health
Panelists:

Christina Weir, Director, Innovation, HIGHMARK HEALTH

12:30PM
Panel Discussion "LEVERAGE"
Making Digital Health Work in Life Sciences - Lessons Learned From Digital Health Leaders Who Are Running Successful Programs in the Market Today
Moderator:

Larry Brooks, Principal, Digital Health Practice Leader, EVOLUTION ROAD

Panelists:

Amanda Goltz, Vice President, Digital, BIOCOMPATIBLES INC., A BTG INTERNATIONAL GROUP COMPANY
Bryan Mallitz, Director, Digital Health Strategy and Solutions, MERCK VACCINES
Dhiren Patel, Pharm.D., Vice President of Medical Affairs, PACKHEALTH
Brent Rose, Executive Director, Consumer/Patient Marketing I&I, CELGENE

1:00PM
TECHNOLOGY DISRUPTORS SHOWCASE
Juanjo Francesch, Vice President, Commercial IT, BRISTOL-MYERS SQUIBB
1:30PM
PHARMA KEYNOTE "COLLABORATE"
Voice Tech, Pharma and Digital Health: Developing Overarching Guidelines, New Concepts, Tactics and Platforms Alongside Your Brand Teams
2:00PM
Networking Luncheon
3:00PM
PHARMA KEYNOTE
The Who, What, When, Where and How of Digital Health

To many Pharma companies, Digital Health brings to mind initiatives focusing on what innovations we can deliver and how they can benefit our patients. However, who these patients are and where and when they are interacting with Pharma brands can sometimes receive less attention. Nevertheless, these considerations are vitally important to creating solutions that provide lasting value. In this session, we’ll explore ways to develop digital health initiatives that fully integrate all the customers’ needs.

3:30PM
PHARMA KEYNOTE
Will Amazon, Apple, Google or Another Emerging Non-Traditional Pharma Entity Completely Disrupt Healthcare and Life Science?
4:00PM
Closing Remarks and Close of Conference

Download the Conference Brochure

Get all of the latest information for this event! Download Now
live chat software